HOYA MiYOSMART Myopia Management Lens (Free Selected Kids Frame) Redemption applicable to selected branches in Hong Kong (ECOM3322)

• Professional eye examination service conducted by government-registered optometrist
• Frame come with 12-month warranty and 60-days for lens refractive guarantee*
• Redemption applicable to selected branches in Hong Kong

Brand of lens:

HOYA MiYOSMART Myopia Management Lens

Brands of selected kids frame:

MASUKU、INTERLUDE、POCO．HIPPO 、88 KIDS、GIANTINO、LIZOM、DELVINA

(Only available for frames with original price of $600 or less)

Product specifications and features:

A revolutionary patented technology

With the exclusive non-invasive D.I.M.S. Technology, the lens corrects the visual defect on its entire surface and has a ring shaped treatment area to slow down myopia progression. The alternation of the focus area and defocus area provides clear vision and manages myopia simultaneously.

A child-friendly, safe and effective non-invasive method

During the 6-year clinical trial no adverse event was reported that would have led to discontinuation of the treatment.

The lens is a very effective method to manage myopia and can be fitted to a child at any age like regular single vision lens.

An award-winning, breakthrough ophthalmic lens, patented with D.I.M.S. technology

MiYOSMART’s efficacy is based on patent protected D.I.M.S. islands creating myopic defocus effect.

In 2018, the MiYOSMART lens won the Gold Prize, Grand Award & Special Gold Award Int’l Exhibition of Inventions of Geneva, Switzerland. In 2020, it won the Silmo d’Or Award in the Vision category at the Silmo Paris Optical Fair.

Appreciated by parents

MiYOSMART has data-driven proof of its effectiveness, with more than 500K patients/wearers.

Parents are happy with the value for money.

They appreciated the Eye Care Professional 6 month protocol and follow-up actions.

Lens power range:

-10/+4 (TP -10)

- Shortsightedness power range within -10.00D 

- Astigmatic power range within -4.00D

- Shortsightedness+ Astigmatic power range within -10.00D (astigmatic power range within -4.00D)

*Not applicable for farsightedness

 

About OPTICAL 88

With over 60 shops in Hong Kong, OPTICAL 88 is the largest network of eyewear stores. OPTICAL 88 offers a broad and diverse choice of product types and styles as well as professional eye examination services. Over the years it has gained customers' support and also recognition as a leader in the industry.

 

T&C

• Redemption is valid for 90 days from the date of issue. 

• Offer is applicable to redeem in shop from Monday to Friday (11am to 8pm, exclude Public Holidays). 

• Offer is only applicable to redeem in the selected branch, no alteration or cancellation can be made once the redemption branch is confirmed.

• Offer is applicable to selected lens and require mandatory purchase of frame with full payment, not available for foreign frames.

• Offer is only applicable to designated brands and models only. If customer wishes to upgrade lens or frame, price difference will be borne by customers. Please direct any queries to the staff for details.

• Photos are for reference only, may vary from shop to shop. Frame available while stock lasts. Please direct any queries to the staff for details.

• Offer cannot be used in conjunction with any other promotions or other discounts. 

• Offer is invalid once expired. No redemption and/or refund is applicable to this offer.

• In case of any disputes, OPTICAL 88 LIMITED reserves the right for final decision.

 

HOYA MiYOSMART Spectacle lenses for Myopia Management

Myopia (short-sightedness) has been the most prevalent visual problem amongst children. Clinical study found that the peak period of myopia progression of Chinese children is between the ages of 6-10¹. Children whose parents both have myopia are more likely to develop myopia². Changes in lifestyle such as more frequent use of digital devices has increased their time spent on reading at close distances and reduced outdoor activities. This is likely to give rise to rapid myopia progression and result in high myopia.

People with high myopia have to rely on their glasses heavily, which brings about inconvenience in daily life. The higher the myopia, the more fragile the retina is. It also increases the risk of suffering from eye diseases such as cataract, glaucoma^{3, 4} and retinal detachment. Therefore, we should be cautious to the myopia development in our children. Appropriate treatments should be taken to control myopia progression so that children can maintain clear vision during their precious period of school life.

MiYOSMART is the spectacle lenses for myopia management developed by The Hong Kong Polytechnic University and HOYA. MiYOSMART won the Grand Prize at the 46^th International Exhibition of Inventions of Geneva. It is designed with Defocus Incorporated Multiple Segments (DIMS) technology. Research showed that MiYOSMART slowed down myopia progress by 60%⁵ in participating children. 20% of the children had their myopia progression stopped completely!

Reference:

1. Lam CS, Edwards M et al. A 2-year longitudinal study of myopia progression and optical component changes among Hong Kong schoolchildren. Optom Vis Sci 1999 Jun; 76(6):370-80.

2. Mutti DO, Mitchell GL et al. Parental myopia, near work, school achievement, and children’s refractive error. Invest Ophthalmol Vis Sci 2002 Dec; 43(12):3633-40.

3. Kubo E, Kumamoto Y et al. Axial length, myopia and the severity of lens opacity at the time of cataract surgery. Arch Ophthalmol 2006 Nov; 124(11):1586-90.

4. Perera SA, Wong TY et al. Refractive error, axial dimensions, and primary open-angle glaucoma: the Singapore Malay eye study. Arch Ophthalmol 2010 Jul; 128(7):900-5.

5. Myopia progression (SER) by 59% and axial elongation (AL) decreased by 60% compared with those wearing SV lenses. Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To Ch. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. British Journal of Opthalmology. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739=